T2 Biosystems Retained Earnings (Accumulated Deficit) 2013-2024 | TTOO
T2 Biosystems retained earnings (accumulated deficit) from 2013 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| T2 Biosystems Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-584 |
| 2022 | $-534 |
| 2021 | $-472 |
| 2020 | $-423 |
| 2019 | $-376 |
| 2018 | $-317 |
| 2017 | $-266 |
| 2016 | $-204 |
| 2015 | $-149 |
| 2014 | $-104 |
| 2013 | $-90 |
| 2012 | $-63 |
| T2 Biosystems Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-607 |
| 2024-03-31 | $-598 |
| 2023-12-31 | $-584 |
| 2023-09-30 | $-574 |
| 2023-06-30 | $-559 |
| 2023-03-31 | $-552 |
| 2022-12-31 | $-534 |
| 2022-09-30 | $-524 |
| 2022-06-30 | $-507 |
| 2022-03-31 | $-489 |
| 2021-12-31 | $-472 |
| 2021-09-30 | $-460 |
| 2021-06-30 | $-446 |
| 2021-03-31 | $-434 |
| 2020-12-31 | $-423 |
| 2020-09-30 | $-413 |
| 2020-06-30 | $-402 |
| 2020-03-31 | $-391 |
| 2019-12-31 | $-376 |
| 2019-09-30 | $-362 |
| 2019-06-30 | $-348 |
| 2019-03-31 | $-332 |
| 2018-12-31 | $-317 |
| 2018-09-30 | $-302 |
| 2018-06-30 | $-291 |
| 2018-03-31 | $-279 |
| 2017-12-31 | $-266 |
| 2017-09-30 | $-248 |
| 2017-06-30 | $-234 |
| 2017-03-31 | $-218 |
| 2016-12-31 | $-204 |
| 2016-09-30 | $-189 |
| 2016-06-30 | $-176 |
| 2016-03-31 | $-162 |
| 2015-12-31 | $-149 |
| 2015-09-30 | $-137 |
| 2015-06-30 | $-125 |
| 2015-03-31 | $-114 |
| 2014-12-31 | $-104 |
| 2014-09-30 | $-95 |
| 2014-06-30 | $-107 |
| 2014-03-31 | $-98 |
| 2013-12-31 | $-90 |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | $-63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.010B | $0.007B |
| T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.041B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $191.072B | 99.90 |
| Alcon (ALC) | Switzerland | $45.679B | 32.16 |
| IQVIA Holdings (IQV) | United States | $39.790B | 21.92 |
| Edwards Lifesciences (EW) | United States | $39.062B | 24.81 |
| IDEXX Laboratories (IDXX) | United States | $35.479B | 41.78 |
| DexCom (DXCM) | United States | $27.326B | 41.15 |
| Waters (WAT) | United States | $22.831B | 33.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.110B | 0.00 |
| STERIS (STE) | Ireland | $21.616B | 24.91 |
| Hologic (HOLX) | United States | $18.294B | 19.30 |
| Sysmex ADR (SSMXY) | Japan | $12.864B | 40.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.499B | 12.83 |
| Globus Medical (GMED) | United States | $10.952B | 27.89 |
| Teleflex (TFX) | United States | $9.082B | 14.49 |
| Penumbra (PEN) | United States | $9.075B | 88.89 |
| Masimo (MASI) | United States | $8.696B | 42.08 |
| Glaukos (GKOS) | United States | $7.816B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.170B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.587B | 26.00 |
| Inari Medical (NARI) | United States | $3.009B | 0.00 |
| TransMedics (TMDX) | United States | $2.886B | 91.47 |
| LivaNova (LIVN) | United Kingdom | $2.804B | 16.18 |
| Veracyte (VCYT) | United States | $2.802B | 84.84 |
| Nihon Kohden (NHNKY) | Japan | $2.648B | 20.12 |
| Elekta AB (EKTAY) | Sweden | $2.286B | 18.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.010B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.912B | 9.99 |
| RxSight (RXST) | United States | $1.776B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.333B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.203B | 79.75 |
| OPKO Health (OPK) | United States | $1.060B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.938B | 15.95 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.741B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 38.68 |
| Mesa Laboratories (MLAB) | United States | $0.643B | 15.22 |
| SiBone (SIBN) | United States | $0.639B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.627B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.623B | 0.00 |
| Paragon 28 (FNA) | United States | $0.597B | 0.00 |
| AxoGen (AXGN) | United States | $0.555B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.501B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.360B | 19.51 |
| ClearPoint Neuro (CLPT) | United States | $0.321B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.293B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.289B | 19.43 |
| Inogen (INGN) | United States | $0.263B | 0.00 |
| NeuroPace (NPCE) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.158B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| 908 Devices (MASS) | United States | $0.124B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.111B | 16.51 |
| EDAP TMS S.A (EDAP) | France | $0.095B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.056B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.041B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |